Abstract
We describe the first case, to our knowledge, of successful desensitization to febuxostat in a young high-risk patient of Filipino descent with HLA-B*58:01 positive genotype and previous drug-induced Stevens-Johnson Syndrome (SJS), with 2 subsequent episodes of a morbilliform rash with repeat exposures to febuxostat.